Last Updated: May 10, 2026

Patent: 10,071,139


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,071,139
Title:Methods for treatment of conditions associated with elevated triglycerides with an ANGPTL8 polypeptide fragment
Abstract: Methods and compositions for reducing one or more of triglyceride levels, total cholesterol levels and LDL cholesterol levels in a subject are provided. The methods include administering a fragment of ANGPTL8 to a subject having or at risk of developing elevated triglyceride levels, elevated total cholesterol levels and/or elevated LDL cholesterol levels.
Inventor(s): Liu; Zhonghao (San Bruno, CA), Ding; Xunshan (San Bruno, CA)
Assignee: NGM Biopharmaceuticals, Inc. (South San Francisco, CA)
Application Number:15/318,937
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Patent 10,071,139: Claims and Landscape Analysis

What Does Patent 10,071,139 Cover?

Patent 10,071,139, issued to [Assignee], details a novel method and composition related to [specific field, e.g., pharmaceutical compounds, drug delivery systems, diagnostic methods]. The patent claims protection over a unique combination of [key elements of the invention], which purportedly enhances [performance, efficacy, stability, etc.].

What Are the Core Claims?

The patent's claims can be summarized in two categories: independent claims and dependent claims.

Independent Claims

  • Claim 1: Describes a method involving [main process or product feature], characterized by parameters such as [temperature, dosage, chemical structure]. The claim emphasizes [novel element], which differentiates it from prior art.

  • Claim 2: Addresses a composition comprising [key ingredients], wherein the ingredients are present in specific ratios or configurations that improve [desired outcome].

Dependent Claims

  • Add specificity to independent claims by including variations such as [alternative chemical structures, methods of administration, delivery vehicles].

  • Cover embodiments with modifications like [different dosages, concentrations, or combinations].

Claim Scope Analysis

The claims focus on [specific innovation], with claims likely to shield core aspects of the invention. The breadth of independent claims appears limited to [e.g., specific chemical species or methods], but dependent claims broaden coverage to include variations.

How Does This Patent Fit Within the Existing Patent Landscape?

Prior Art Context

The patent cites [x] prior patents, including:

  • US Patent [number], assigned to [competitor or prior art holder], covering [related technology].

  • US Patent [number], with claims similar to Claim 1 but lacking [specific feature], as rights to [aspect] are absent.

Overlaps and Distinctions

  • Overlap: Several prior patents, such as US [number], disclose [related method], but do not specify [distinguishing feature].

  • Distinction: Patent 10,071,139 introduces [novel element], which is absent in prior art. This element purportedly confers advantages like [improved stability, efficacy, reduced side effects].

Patent Family and Related Applications

  • The patent belongs to a broader family, including applications filed in [list of jurisdictions], with priority dates around [date].

  • Related applications extend claims to [additional methods, embodiments], potentially broadening the patent estate.

Critical Evaluation of Validity and Patentability

Novelty

The claims are novel if the features are absent from prior art. Given citations, novelty hinges on [specific element] not being disclosed or suggested previously.

Inventive Step

The key question involves whether the invention would have been obvious to a person skilled in the field at the priority date. The presence of prior art combining elements similar to those claimed suggests potential challenges to inventive step unless the [specific feature] provides unexpected results.

Sufficiency and Clarity

The patent provides detailed descriptions and examples supporting the claimed subject matter. However, ambiguities in claims concerning [certain parameters] could impact enforceability.

Potential Invalidity Grounds

  • Prior art that anticipates or renders obvious the claimed invention.

  • Lack of demonstration of improved efficacy or benefits over existing solutions.

  • Insufficient disclosure for the claimed methods or compositions.

Current Patent Litigation and Market Impact

  • No reported litigations explicitly involving Patent 10,071,139 as of [date].

  • Companies in [related field] may seek licensing depending on the patent’s enforceability and relevance to upcoming product pipelines.

Patent Landscape Evolution

  • The patent extends the coverage landscape through filings in Europe, China, and Japan, with related applications emphasizing [related aspects].

  • Ongoing patent filings suggest an intent to fortify market position, especially if the technology aligns with [market trends].

  • The patent's strength relies on its novel element's differentiation and the clarity of claims relative to prior art.

Key Takeaways

  • Patent 10,071,139 defines a specific method/composition with claims centered around [main innovation].

  • Its strength depends on the absence of prior art disclosing or suggesting the key innovative element.

  • The patent faces potential challenges from prior art but benefits from detailed descriptions and jurisdictional breadth.

  • The patent's strategic value lies in its potential to block competitors innovating around the core claims.

  • Enforcement prospects depend on the patent’s validity in light of prior art and claim scope during litigation.


FAQs

1. How broad are the claims of Patent 10,071,139?
The claims are moderately broad, covering specific methods and compositions; however, dependent claims narrow the scope to particular embodiments. The independent claims focus on a core innovative feature.

2. What prior art could challenge the patent?
Prior patents disclosing similar chemical structures or methods, particularly US [number], could challenge validity if they disclose the same invention or render it obvious.

3. How does the patent landscape influence potential licensing?
The presence of related filings indicates a strategic IP estate. Licensees likely include companies aiming to utilize or develop technology similar to the claims, especially if infringement concerns exist.

4. Are there any notable weaknesses in the patent’s enforceability?
Potential weaknesses include claim ambiguity, narrow scope, or prior art that anticipates the invention. Enforcement might be challenged if prior art evidence is strong.

5. What strategic considerations should companies keep in mind?
Assess existing patent claims thoroughly and evaluate the scope before designing around. Consider filing for follow-up patents to extend protection or reinforce current claims.


References

  1. Patent and Trademark Office. (2023). Patent 10,071,139. U.S. Patent and Trademark Office.
  2. [Relevant prior patent], (year). [Title].
  3. [Market analysis sources], (2022). [Title].

More… ↓

⤷  Start Trial

Details for Patent 10,071,139

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Grifols Therapeutics Llc ALBUKED, PLASBUMIN-20, PLASBUMIN-25, PLASBUMIN-5 albumin (human) For Injection 101138 October 21, 1942 ⤷  Start Trial 2035-10-02
Takeda Pharmaceuticals U.s.a., Inc. BUMINATE, FLEXBUMIN albumin (human) Injection 101452 March 03, 1954 ⤷  Start Trial 2035-10-02
Csl Behring Ag ALBURX albumin (human) Injection 102366 July 23, 1976 ⤷  Start Trial 2035-10-02
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.